AGORACOM Small-cap Investor Relations Blog

Kai Medical Laboratory, a state-of-the-art diagnostics laboratory in Dallas, TX was acquired by Empower Clinics on October 6, 2020 to further advance the Company’s COVID-19 national testing programs for enterprise clients, including movie and television studios, businesses and travel industry

• Announced KAI Medical Laboratory (“KAI LAB”) has exceeded 1,000 COVID-19 test units in a single day for the first time.
• As a result, Empower is announcing that KAI LAB will undergo an even larger expansion in anticipation of projected growth in COVID-19 test requirements in the U.S., Canada and international markets.

VANCOUVER BC / February 16, 2021 / EMPOWER CLINICS INC. (CSE:CBDT)(OTCQB:EPWCF)(Frankfurt:8EC) (“Empower” or the “Company“) an integrated healthcare company serving patients through medical centres, telemedicine platforms, operating a high complexity medical diagnostics laboratory processing thousands of COVID-19 specimens, is pleased to announce our KAI Medical Laboratory (“KAI LAB”) has exceeded 1,000 COVID-19 test units in a single day for the first time.

As a result, Empower is announcing that KAI LAB will undergo an even larger expansion in anticipation of projected growth in COVID-19 test requirements in the U.S., Canada and international markets.

KAI MEDICAL LABORATORY NOW EXPANDING TO TRIPLE CURRENT SIZE IN ANTICIPATION OF ANTICIPATED RAPID TEST GROWTH

KAI Medical Laboratory, a state-of-the-art diagnostics laboratory in Dallas, TX was acquired by Empower Clinics on October 6, 2020 to further advance the Company’s COVID-19 national testing programs for enterprise clients, including movie and television studios, businesses and the travel industry. KAI experienced significant growth in its first quarter under Empower (October 2020 – December 2020), with Q4 COVID-19 test units exceeding 6,000 specimens processed, far surpassing the less than 1,000 total monthly units prior to acquisition.

As a result, on January 21st, Empower announced “Doubling KAI Medical Laboratory In Anticipation Of Test Volumes By End Of Q1.” The Company is revising this planned expansion upwards by announcing KAL LAB is now expanding by tripling its current size in anticipation of projected growth in COVID-19 test requirements.

Empower Clinics Chairman & CEO, Steven McAuley stated “Today marks a significant milestone for Empower and our shareholders. When we first acquired KAI Medical Laboratory just over four months ago, it was processing less than 1,000 specimens monthly up to that point. Today, we are announcing that KAI has surpassed 1,000 units in a day for the first time ever. This is a credit to both Yoshi Tyler, President KAI LAB and her fantastic team, supported by our business development and marketing strategies which, quite frankly, are still in an early phase. We are just getting started.”

For the purposes of facilitating the expansion, Empower has secured additional space adjacent to KAI LAB in order to separate the lab & science from logistics, admin and customer support. Materials handling staff are being added in anticipation of processing the intake of thousands of packages per day.

This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/EmpowerClinics

Read More: https://agoracom.com/ir/EmpowerClinics/forums/discussion/topics/755396-empower-clinics-kai-medical-laboratory-surpasses-1-000-covid-19-tests-in-a-day-for-the-first-time-ever-kai-laboratory-now-tripling-in-size/messages/2303796#message

• Announced it has secured Medical Device Establishment Licence (“MDEL”) status to sell its KAI Medical COVID-19 Saliva Test kits (“KAI Saliva”).
• KAI Saliva is FDA EUA approved for use, has CE Mark and the saliva specimen collection device is approved by Health Canada.
• KAI Saliva provides travellers, both foreign and domestic with a simple, fully compliant method to obtain an RT-PCR test and test result prior to arriving or coming back into to Canada or arriving to other countries that have similar executive travel orders.

VANCOUVER BC / February 10, 2021 / EMPOWER CLINICS INC. (CBDT:CSE) (8EC:Frankfurt) (EPWCF:OTCQB) (“Empower” or the “Company“) an integrated healthcare company serving patients through medical centres, telemedicine platforms, operating a high complexity medical diagnostics laboratory processing thousands of COVID-19 specimens, is pleased to announce it has secured Medical Device Establishment Licence (“MDEL”) status to sell its KAI Medical COVID-19 Saliva Test kits (“KAI Saliva”).

KAI Saliva is FDA EUA approved for use, has CE Mark and the saliva specimen collection device is approved by Health Canada. KAI Saliva provides travellers, both foreign and domestic with a simple, fully compliant method to obtain an RT-PCR test and test result prior to arriving or coming back into to Canada or arriving to other countries that have similar executive travel orders.

EMPOWER ACCELERATES ABILITY TO DISTRIBUTE AND SELL MEDICAL DEVICE PRODUCTS IN CANADA THROUGH PARTNERSHIP WITH MEDIPRO CANADA

Empower previously announced the filing of an MDEL application for the purpose of importing, distributing and selling KAI Saliva, which has experienced success upon its launch.

To accelerate the process, Empower partnered with MediPro Canada Inc. (“MediPro”) to utilize their approved MDEL status. MediPro provides healthcare products for governments, large corporations and medical facilities around the world and is led by Hon. Sheila Maureen Copps PC OC.

“We continue to see extensive demand for novel COVID-19 testing products in both private sector and public sector markets throughout North America, Mexico and Caribbean countries.” said Hon. Sheila Copps OC, Partner MediPro Canada. “Leveraging the vast network of MediPro Canada with the integrated healthcare capabilities of Empower Clinics and their novel COVID-19 testing products, makes for an ideal partnership.”

“We all have an urgent requirement for a home-based, self-administered COVID-19 saliva test kit that can help open up the economy and facilitate travel that meets the requirements of the executive travel orders.” said Steven McAuley, Chairman & CEO. “We also must utilize our resources, our reach, our capability, do everything we can to assist, be humanitarians, use our voice, strive to provide improved healthcare, and lead the path of progressive healthcare.”

Read More: https://agoracom.com/ir/EmpowerClinics/forums/discussion/topics/755072-empower-clinics-secures-medical-device-establishment-licence-mdel-status-to-sell-kai-saliva-covid-19-pcr-test-kits-in-canada/messages/2303015#message

• Awarded a long-term COVID-19 testing and healthcare management program for the Dallas Market Center, the leading wholesale marketplace in North America and the most complete wholesale trade resource in the world.
• DMC is a five million square foot, global business-to-business trade center and the leading wholesale marketplace in North America connecting retailers and interior designers with top manufacturers in home décor, furniture, gifts, lighting and fashion.

VANCOUVER BC / February 1, 2021 / EMPOWER CLINICS INC. (CBDT:CSE) (EPWCF:OTCQB) (8EC:Frankfurt) (“Empower” or the “Company“) an integrated healthcare company serving patients through clinics, a telemedicine platform, and a leading medical diagnostics laboratory processing thousands of COVID-19 specimens each month, developing novel COVID-19 testing protocols for CE, FDA EUA and Health Canada approval, is pleased to announce that KAI Medical Laboratory has been awarded a long-term COVID-19 testing and healthcare management program for the Dallas Market Center (“DMC”), the leading wholesale marketplace in North America and the most complete wholesale trade resource in the world.

KAI TO PROVIDE DAILY ONSITE COVID TESTING TO KEEP FIVE MILLION SQUARE FOOT TRADE CENTER OPEN TO BUYERS AND SELLERS FROM AROUND THE WORLD

DMC is a five million square foot, global business-to-business trade center and the leading wholesale marketplace in North America connecting retailers and interior designers with top manufacturers in home décor, furniture, gifts, lighting and fashion. DMC markets events throughout the year attracting buyers and sellers from all 50 states and more than 80 countries, resulting in significant economic impact:

• $8 Billion in annual wholesale transactions
• $1.1 Billion in indirect local economic impact
• $380 million in direct local economic impact

“We cannot recover from crises like the COVID-19 pandemic without a resilient retail sector and the market centers have a critical role in participating in that recovery,” said Harlan Crow, chairman of the company that owns DMC in a January 3, 2021 Forbes Article.

Read More: https://agoracom.com/ir/EmpowerClinics/forums/discussion/topics/754316-empower-clinics-subsidiary-kai-medical-laboratory-awarded-covid-19-testing-healthcare-management-program-for-five-million-square-foot/messages/2301340#message